Drugs / BLB-750
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03370289 | Jan → Feb 2018 | — | Takeda | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BLB-750 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03370289 ↗ |
| Modality | Vaccine | “BLB-750 that is a vaccine for pandemic influenza infection” NCT03370289 ↗ |
| Route | Intramuscular | “Two intramuscular vaccinations of BLB-750 at 3-week intervals” NCT03370289 ↗ |